个人简历

教育背景
2011.09-2014.07 天津医科大学，医学博士
2007.09-2009.06 天津大学，材料学硕士
2003.09-2007.06 天津大学，材料学学士
工作经历
2017.12- 天津医科大学 基础医学院遗传学系 副教授
2016.06-2017.11 天津医科大学基础医学院遗传学系 讲师
2012.12-2016.05 天津医科大学 基础医学研究中心 助理研究员
2009.7-2012.11 天津医科大学基础医学研究中心 助理实验师
荣誉奖励
2015 年并评为天津市“131”创新型人才培养工程第三层次人才

研究领域

肿瘤转移与药物耐受

近期论文

Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, Song X, Zhu ZY, Sun T, Dou Y, Tian WP, Zhao XL, Kang CS, Mei M. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion. Mol Cancer. 2018 Jan 11;17(1):5.
Ren Y, Wang YF, Zhang J, Wang QX, Han L, Mei M, Kang CS. Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2. Clin Epigenetics. 2019 Feb 14;11(1):29.
Ren Y, Wang R, Liu Y, Guo H, Zhou X, Yuan X, Liu C, Tian J, Yin H, Wang Y, Zhang N. A hematoporphyrin-based delivery system for drug resistance reversal and tumor ablation. Biomaterials 2014 Mar; 35(8):2462-70.
Ren Y, Wang R, Gao L, Li K, Zhou X, Guo H, Liu C, Han D, Tian J, Ye Q, Hu YT, Sun D, Yuan X, Zhang N. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy. J Control Release. 2016 Apr 28; 228:74-86.
Ren Y, Zhou X, Liu X, Jia HH, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Sun T, Jiao HX, Tian WP, Yang YQ, Zhao XL, Zhang L, Mei M, Kang CS. Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy. Cancer Lett. 2016 Apr 28; 374(1):96-106.
Ren Y, Zhou X, Yang JJ, Liu X, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Tian WP, Zhang L, Mei M, Kang CS. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis. Cancer Lett. 2015 Jul 1; 362(2):174-82.
Xu Y, Zhou X, Mei M, Ren Y*. Reprogramming carcinoma associated fibroblasts by microRNA. Current Molecular Medicine. 2017；17(5)：314-349.
Qian X, Long L, Shi Z, Liu C, Qiu M, Sheng J, Pu P, Yuan X, Ren Y*, Kang C. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Biomaterials 2014 Feb; 35(7):2322-35.
Sun S, Zhou X, Huang Y, Kong L, Mei M, Guo W, Zhao M, Ren Y*, Shen Q, Zhang L. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma. Molecular Cancer (2015) 14:213